Digital Therapeutics

London, United Kingdom Founded: 2015 • Age: 11 yrs
Behavior therapy app for smoking cessation is developed and offered.
Annual revenue - Latest available
Total funding $23.6M 2 rounds
Employees 26 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 6 Brand Intelligence

About Digital Therapeutics

Digital Therapeutics is a company based in London (United Kingdom) founded in 2015 by Maroof Ahmed, Yusuf Sherwani, and Sarim Siddiqui. Digital Therapeutics has raised $23.64 million across 2 funding rounds. The company has 26 employees as of January 31, 2021. Digital Therapeutics operates in a competitive market with competitors including 2Morrow, Kwit, Vincere Health, KLAVA Innovation and Smoker Reducer, among others.

  • Headquarter London, United Kingdom
  • Employees 26 as on 31 Jan, 2021
  • Founders Maroof Ahmed, Yusuf Sherwani, Sarim Siddiqui
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Digital Therapeutics Ltd
  • Date of Incorporation 02 Nov, 2015
  • Jurisdiction HOLBORN, LONDON, ENGLAND
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $23.64 M (USD)

    in 2 rounds

  • Latest Funding Round
    $11.5 M (USD), Series B

    Jul 27, 2022

  • Investors
    Not available
  • Employee Count
    26

    as on Jan 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Digital Therapeutics

Digital Therapeutics has successfully raised a total of $23.64M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $11.5 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Digital Therapeutics

Investments
Premium access

Investment portfolio details for Digital Therapeutics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Digital Therapeutics

Premium access

Detailed financials for Digital Therapeutics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Digital Therapeutics Comparisons

Digital Therapeutics Primary company
Description
Behavior therapy app for smoking cessation is developed and ...
Location
London, United Kingdom
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
26
As of 2021
Premium access

Peer comparison for Digital Therapeutics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Digital Therapeutics

Digital Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 2Morrow, Kwit, Vincere Health, KLAVA Innovation and Smoker Reducer, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Evidence-based smoking cessation program is delivered via smartphone app.
Locked Locked Locked
App for managing smoking addiction via gamification is provided.
Locked Locked Locked
Provider of a mobile app to manage smoking addiction
Locked Locked Locked
Developer of digital therapeutics for addictive disorders
Locked Locked Locked
Provides web hosting, drag-and-drop builders, and free website migrations for users.
Premium access

Detailed competitors of Digital Therapeutics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Digital Therapeutics

Premium access

Complete news archive for Digital Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digital Therapeutics

Digital Therapeutics was founded in 2015 and raised its 1st funding round 5 years after it was founded.

Digital Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Digital Therapeutics is a funded company, having raised a total of $23.64M across 2 funding rounds to date.

As of Jan 31, 2021, the latest employee count at Digital Therapeutics is 26.

Digital Therapeutics was founded in 2015 in London, United Kingdom, within the digital health sector. An app named Quit Genius is provided for behavior therapy aimed at smoking cessation. Smoking patterns of users are tracked and analyzed by coaches through the app, with personalized advice delivered accordingly. Videos, audio sessions, challenges, and cognitive behavioral therapy exercises are incorporated to support users in their quitting efforts.

Digital Therapeutics's top competitors include 2Morrow, Kwit and Vincere Health.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available